Annual CFF
$11.54 M
+$13.16 M+810.42%
December 1, 2023
Summary
- As of February 7, 2025, PTPI annual cash flow from financing activities is $11.54 million, with the most recent change of +$13.16 million (+810.42%) on December 1, 2023.
- During the last 3 years, PTPI annual CFF has fallen by -$18.77 million (-61.93%).
- PTPI annual CFF is now -61.93% below its all-time high of $30.30 million, reached on December 31, 2020.
Performance
PTPI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$2.77 M
-$816.60 K-41.70%
September 1, 2024
Summary
- As of February 7, 2025, PTPI quarterly cash flow from financing activities is -$2.77 million, with the most recent change of -$816.60 thousand (-41.70%) on September 1, 2024.
- Over the past year, PTPI quarterly CFF has dropped by -$17.41 million (-118.97%).
- PTPI quarterly CFF is now -111.55% below its all-time high of $24.02 million, reached on December 31, 2021.
Performance
PTPI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$8.23 M
-$17.41 M-189.64%
September 1, 2024
Summary
- As of February 7, 2025, PTPI TTM cash flow from financing activities is -$8.23 million, with the most recent change of -$17.41 million (-189.64%) on September 1, 2024.
- Over the past year, PTPI TTM CFF has dropped by -$21.95 million (-159.95%).
- PTPI TTM CFF is now -127.15% below its all-time high of $30.30 million, reached on December 31, 2020.
Performance
PTPI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PTPI Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +810.4% | -119.0% | -159.9% |
| 3 y3 years | -61.9% | -675.5% | -660.5% |
| 5 y5 years | +471.1% | -675.5% | -660.5% |
PTPI Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.9% | +810.4% | -111.5% | at low | -136.4% | at low |
| 5 y | 5-year | -61.9% | +471.1% | -111.5% | at low | -127.2% | at low |
| alltime | all time | -61.9% | +471.1% | -111.5% | at low | -127.2% | at low |
Petros Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.77 M(+41.7%) | -$8.23 M(-189.6%) |
| Jun 2024 | - | -$1.96 M(+74.6%) | $9.18 M(-14.8%) |
| Mar 2024 | - | -$1.12 M(-52.7%) | $10.77 M(-6.6%) |
| Dec 2023 | $11.54 M(-810.4%) | -$2.37 M(-116.2%) | $11.54 M(-15.9%) |
| Sep 2023 | - | $14.63 M(-4128.5%) | $13.73 M(-1182.4%) |
| Jun 2023 | - | -$363.20 K(+1.5%) | -$1.27 M(+17.2%) |
| Mar 2023 | - | -$357.80 K(+93.3%) | -$1.08 M(-33.4%) |
| Dec 2022 | -$1.62 M | -$185.10 K(-48.9%) | -$1.62 M(-107.2%) |
| Sep 2022 | - | -$362.00 K(+104.5%) | $22.58 M(+6.2%) |
| Jun 2022 | - | -$177.00 K(-80.3%) | $21.26 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$900.00 K(-103.7%) | $19.80 M(+6.6%) |
| Dec 2021 | $18.57 M(-38.7%) | $24.02 M(-1525.7%) | $18.57 M(+19.4%) |
| Sep 2021 | - | -$1.68 M(+3.0%) | $15.55 M(-21.2%) |
| Jun 2021 | - | -$1.64 M(-23.1%) | $19.74 M(-26.4%) |
| Mar 2021 | - | -$2.13 M(-110.1%) | $26.80 M(-11.6%) |
| Dec 2020 | $30.30 M(-1074.6%) | $20.99 M(+738.2%) | $30.30 M(+225.5%) |
| Sep 2020 | - | $2.50 M(-53.9%) | $9.31 M(+36.8%) |
| Jun 2020 | - | $5.43 M(+294.7%) | $6.81 M(+394.7%) |
| Mar 2020 | - | $1.38 M | $1.38 M |
| Dec 2019 | -$3.11 M | - | - |
FAQ
- What is Petros Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual CFF year-on-year change?
- What is Petros Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly CFF year-on-year change?
- What is Petros Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals TTM CFF year-on-year change?
What is Petros Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of PTPI is $11.54 M
What is the all time high annual CFF for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual cash flow from financing activities is $30.30 M
What is Petros Pharmaceuticals annual CFF year-on-year change?
Over the past year, PTPI annual cash flow from financing activities has changed by +$13.16 M (+810.42%)
What is Petros Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of PTPI is -$2.77 M
What is the all time high quarterly CFF for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly cash flow from financing activities is $24.02 M
What is Petros Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, PTPI quarterly cash flow from financing activities has changed by -$17.41 M (-118.97%)
What is Petros Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of PTPI is -$8.23 M
What is the all time high TTM CFF for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high TTM cash flow from financing activities is $30.30 M
What is Petros Pharmaceuticals TTM CFF year-on-year change?
Over the past year, PTPI TTM cash flow from financing activities has changed by -$21.95 M (-159.95%)